WHWK · Whitehawk Therapeutics, Inc.

$3.83 -0.16 (-4.01%) At close · Jul 23

Market Cap

$189.40M

49.45M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Lennon	CEO	$676,504	$390,000	$1,318,907	$973,664	—	—	$3,359,075
Scott Giacobello	CFO	$501,561	$220,000	$805,633	$594,747	—	—	$2,121,941
Bryan Ball	Chief Technical Operations Officer	$477,455	$210,000	$623,104	$459,997	—	—	$1,770,556

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Neil Desai	Chairman	$484,512	—	—	—	—	$1,175,239	$1,659,751
Loretta Itri	Chief Medical Officer	$403,936	—	$57,600	$194,543	—	$973,995	$1,630,074
David Lennon	CEO	$654,400	—	$124,800	$232,868	—	—	$1,012,068
Scott Giacobello	CFO	$483,407	—	$51,840	$272,682	—	—	$807,929
Bryan Ball	Chief Technical Operations Officer	$460,173	—	$38,400	$149,998	—	—	$648,571

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Neil Desai	Chairman	$638,040	—	—	$1,451,968	$72,306	—	$2,162,314
David Lennon	CEO	$160,000	$100,000	$139,999	$1,717,935	$17,753	—	$2,135,688
Scott Giacobello	CFO	$469,328	$94,122	—	$1,327,954	$79,780	—	$1,971,183
Brendan Delaney	CEO	$128,000	—	—	$1,451,968	—	$65,047	$1,645,015
Loretta Itri	Chief Medical Officer	$521,475	—	—	$858,234	$44,322	$51,654	$1,475,685

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Neil Desai	Chairman	$618,120	—	—	$1,934,692	$500,000	—	$3,052,812
Loretta Itri	Chief Medical Officer	$507,620	—	—	$849,346	$275,400	$22,830	$1,655,196
Brendan Delaney	CEO	$494,520	—	—	$769,838	$270,000	—	$1,534,358
Scott Giacobello	CEO	$456,870	—	—	$799,936	$247,860	—	$1,504,666

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Brendan Delaney	CEO	$136,615	—	—	$5,491,827	$81,810	—	$5,710,252
Loretta Itri	Chief Medical Officer	$96,794	—	—	$4,967,250	—	—	$5,064,044
Scott Giacobello	CFO	$75,000	—	—	$3,971,027	$45,563	—	$4,091,590
Neil Desai	Chairman	$465,791	$394,000	—	$2,511,538	$315,000	$53,939	$3,740,262
Joseph Gardner	President, Principal Executive Officer	$308,484	—	—	—	—	$1,206,842	$1,515,326

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Gardner	President, Principal Executive Officer	$432,600	$210,000	—	$48,427	$108,150	$1,646	$800,823
Kevin G. Peters	Chief Scientific Officer and acting Chief Medical Officer	$370,800	$180,000	—	$40,304	$74,160	$1,003	$486,267
Regina Marek	Vice President, Principal Financial and Accounting Officer	$278,100	$120,000	—	$29,057	$48,668	$350	$356,175

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Hoffman	CEO	$393,506	—	—	$1,160,363	—	$534,832	$2,088,701
Michael Rogers	Former Chief Financial and Business Officer	$317,178	—	—	$800,036	—	$470,526	$1,587,740
Joseph Gardner	President, Principal Executive Officer	$420,000	—	—	$510,423	$199,500	$1,069	$1,130,992
Kevin G. Peters	Chief Scientific Officer and acting Chief Medical Officer	$360,000	—	—	$450,200	$136,800	$1,069	$948,069
Regina Marek	Vice President, Principal Financial and Accounting Officer	$244,643	—	—	$168,866	$71,708	$373	$485,590

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Hoffman	CEO	$470,000	—	—	$666,595	$305,500	$1,069	$1,443,164
Joseph Gardner	President, Principal Executive Officer	$410,000	—	—	$333,297	$266,500	$1,069	$1,010,866
Michael Rogers	Former Chief Financial and Business Officer	$375,000	—	—	$319,966	$195,000	$697	$890,663
Kevin G. Peters	Chief Scientific Officer and acting Chief Medical Officer	$350,000	—	—	$222,198	$159,250	$1,069	$732,517
Regina Marek	Vice President, Principal Financial and Accounting Officer	$93,750	—	—	$171,357	$36,563	$155	$301,825

Key facts CIK 1422142 CUSIP 00032Q104 13F (30d) 4 filings 4 filers Visit website Investor relations